Insider Transactions in Q1 2023 at Cadrenal Therapeutics, Inc. (CVKD)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2023
|
John Raymond Murphy Director |
BUY
Open market or private purchase
|
Direct |
10,000
+1.65%
|
$10,000
$1.39 P/Share
|
|
Mar 16
2023
|
John Raymond Murphy Director |
BUY
Open market or private purchase
|
Direct |
20,000
+3.36%
|
$20,000
$1.67 P/Share
|
|
Feb 10
2023
|
Quang X Pham CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+0.75%
|
$25,000
$1.94 P/Share
|
|
Jan 24
2023
|
John Raymond Murphy Director |
BUY
Conversion of derivative security
|
Direct |
514,792
+48.13%
|
-
|
|
Jan 24
2023
|
Matthew K Szot Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+9.09%
|
-
|
|
Jan 24
2023
|
Glynn Wilson Director |
BUY
Conversion of derivative security
|
Direct |
50,000
+50.0%
|
-
|